Recent Publications on Proto-Oncogene Proteins C-Raf: |  |
Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives.
A yeast protein fragment complementation assay (PCA) system based on... Direct Link | 15th November, 2008
| Department of Pharmacy, School of Pharmacy, Hyogo University of Health
|
| Knockdown of B-Raf impairs spindle formation and the mitotic checkpoint in human somatic cells.
| 4th November, 2008
| Molecular Oncology Program, H. Lee Moffitt Cancer Center & Research
|
Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37.
Activation of protein kinase clients by the Hsp90 system is mediated by... Direct Link | 31st October, 2008
| Section of Structural Biology, Institute of Cancer Research, Chester
|
CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation.
The CRAF protein kinase regulates proliferative, differentiation, and... Direct Link | 31st October, 2008
| Department of Biochemistry, Henry Wellcome Building, University of
|
The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.
Resveratrol, present in grapes and red wine, is reported to be a natural... Direct Link | 23rd October, 2008
| Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
|
Characterization of the topology and functional domains of RKTG.
RKTG (Raf kinase trapping to Golgi) is exclusively localized at the Golgi... Direct Link | 22nd October, 2008
| Key Laboratory of Nutrition and Metabolism, Institute for Nutritional
|
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.
Heat-shock protein 70 (HSP70) isoforms contribute to tumorigenesis through... Direct Link | 16th October, 2008
| Signal Transduction and Molecular Pharmacology Team, Cancer Research UK
|
Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors.
Understanding molecular mechanisms underlying lung cancer is a... Direct Link | 15th October, 2008
| Molecular Medicine and Medical Biotechnology, Fraunhofer Institute of
|
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Expression and activity of lysosomal cysteine cathepsins correlate with... Direct Link | 3rd October, 2008
| Apoptosis Department and Centre for Genotoxic Stress Response, Institute
|
K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.
The spatial organization of K-Ras proteins into nanoclusters on the plasma... Direct Link | 3rd October, 2008
| Department of Neurobiology, The George S. Wise Faculty of Life Sciences,
|
HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.
Histone deacetylase 6 (HDAC6) is a heat shock protein 90 (hsp90)... Direct Link | 1st October, 2008
| Medical College of Georgia (MCG) Cancer Center, Augusta, GA 30912, USA.
|
Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation.
c-raf is a serine-threonine kinase and a downstream effector of ras... Direct Link | 27th September, 2008
| Fraunhofer Institute of Toxicology and Experimental Medicine,
|
Activation of protein kinase Calpha signaling prevents cytotoxicity and mutagenicity following lead acetate in CL3 human lung cancer cells.
Protein kinase C (PKC) family of serine/threonine protein kinases is... Direct Link | 13th September, 2008
| Molecular Carcinogenesis Laboratory, Institute of Biotechnology &
|
Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells.
Ras/ERK signaling plays an important role in T cell activation and... Direct Link | 30th August, 2008
| Departamento de Biologia Vascular e Inflamacion, Centro Nacional de
|
Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
Activating BRAF kinase mutations arise in approximately 7% of all human... Direct Link | 19th August, 2008
| Center for Molecular Therapeutics, Massachusetts General Hospital Cancer
|